{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T01:55:36Z","timestamp":1776995736992,"version":"3.51.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,3,8]],"date-time":"2020-03-08T00:00:00Z","timestamp":1583625600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,8]],"date-time":"2020-03-08T00:00:00Z","timestamp":1583625600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Clinical research grant from iHOPE International","award":["KJ15-02"],"award-info":[{"award-number":["KJ15-02"]}]},{"name":"Grants-in-Aid for Scientific Research","award":["16K06175"],"award-info":[{"award-number":["16K06175"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s10157-020-01866-z","type":"journal-article","created":{"date-parts":[[2020,3,8]],"date-time":"2020-03-08T05:02:36Z","timestamp":1583643756000},"page":"565-572","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A questionnaire on prescription patterns of proton pump inhibitors for hemodialysis patients in Japan"],"prefix":"10.1007","volume":"24","author":[{"given":"Hiroo","family":"Kawarazaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahide","family":"Furusho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayaka","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0147-5273","authenticated-orcid":false,"given":"Takeshi","family":"Nakata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,8]]},"reference":[{"key":"1866_CR1","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2165\/11598560-000000000-00000","volume":"29","author":"C Parsons","year":"2012","unstructured":"Parsons C, Johnston S, Mathie E, Baron N, Machen I, Amador S, Goodman C. Potentially inappropriate prescribing in older people with dementia in care homes: a retrospective analysis. Drugs Aging. 2012;29:143\u201355.","journal-title":"Drugs Aging"},{"key":"1866_CR2","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1001\/archinternmed.2010.64","volume":"170","author":"MH Katz","year":"2010","unstructured":"Katz MH. Failing the acid test: benefits of proton pump inhibitors may not justify the risks for many users. Arch Intern Med. 2010;170:747\u20138.","journal-title":"Arch Intern Med"},{"key":"1866_CR3","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1001\/archinternmed.2010.89","volume":"170","author":"MD Howell","year":"2010","unstructured":"Howell MD, Novack V, Grgurich P, Soulliard D, Novack L, Pencina M, Talmor D. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch Intern Med. 2010;170:784\u201390.","journal-title":"Arch Intern Med"},{"key":"1866_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.amjmed.2009.05.032","volume":"123","author":"DT Eurich","year":"2010","unstructured":"Eurich DT, Sadowski CA, Simpson SH, Marrie TJ, Majumdar SR. Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs. Am J Med. 2010;123:47\u201353.","journal-title":"Am J Med"},{"key":"1866_CR5","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1001\/jama.296.24.2947","volume":"296","author":"YX Yang","year":"2006","unstructured":"Yang YX, Lewis JD, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA. 2006;296:2947\u201353.","journal-title":"JAMA"},{"key":"1866_CR6","doi-asserted-by":"publisher","first-page":"e0171006","DOI":"10.1371\/journal.pone.0171006","volume":"12","author":"SY Tai","year":"2017","unstructured":"Tai SY, Chien CY, Wu DC, Lin KD, Ho BL, Chang YH, Chang YP. Risk of dementia from proton pump inhibitor use in Asian population: a nationwide cohort study in Taiwan. PLoS ONE. 2017;12:e0171006.","journal-title":"PLoS ONE"},{"key":"1866_CR7","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1136\/gut.2006.108613","volume":"56","author":"C Hutchinson","year":"2007","unstructured":"Hutchinson C, Geissler CA, Powell JJ, Bomford A. Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis. Gut. 2007;56:1291\u20135.","journal-title":"Gut"},{"key":"1866_CR8","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1542-4758.2006.00092.x","volume":"10","author":"GR Bailie","year":"2006","unstructured":"Bailie GR, Mason NA, Elder SJ, Andreucci VE, Greenwood RN, Akiba T, Saito A, Bragg-Gresham JL, Gillespie BW, Young EW. Large variations in prescriptions of gastrointestinal medications in hemodialysis patients on three continents: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Hemodial Int. 2006;10:180\u20138.","journal-title":"Hemodial Int"},{"key":"1866_CR9","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1002\/pds.4043","volume":"25","author":"F Othman","year":"2016","unstructured":"Othman F, Card TR, Crooks CJ. Proton pump inhibitor prescribing patterns in the UK: a primary care database study. Pharmacoepidemiol Drug Saf. 2016;25:1079\u201387.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1866_CR10","first-page":"728","volume":"104","author":"FL Lanza","year":"2009","unstructured":"Lanza FL, Chan FK, Quigley EM, Practice Parameters Committee of the American College of Gastroenterology. Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol. 2009;104:728\u201338.","journal-title":"Am J Gastroenterol"},{"key":"1866_CR11","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1002\/jbmr.3842","volume":"34","author":"M Fusaro","year":"2019","unstructured":"Fusaro M, D'Arrigo G, Pitino A, Iervasi G, Tentori F, Robinson B, Aghi A, Bieber B, Mccullogh K, Fabris F, Plebani M, Giannini S, Gallieni M, Tripepi G. Increased risk of bone fractures in hemodialysis patients treated with proton pump inhibitors in real world: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Bone Miner Res. 2019;34:2238\u201345.","journal-title":"J Bone Miner Res"},{"key":"1866_CR12","doi-asserted-by":"publisher","first-page":"e0143656","DOI":"10.1371\/journal.pone.0143656","volume":"10","author":"A Nakashima","year":"2015","unstructured":"Nakashima A, Ohkido I, Yokoyama K, Mafune A, Urashima M, Yokoo T. Proton pump inhibitor use and magnesium concentrations in hemodialysis patients: a cross-sectional study. PLoS ONE. 2015;10:e0143656.","journal-title":"PLoS ONE"},{"key":"1866_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1471-2369-14-15","volume":"14","author":"CC Kuo","year":"2013","unstructured":"Kuo CC, Kuo HW, Lee IM, Lee CT, Yang CY. The risk of upper gastrointestinal bleeding in patients treated with hemodialysis: a population-based cohort study. BMC Nephrol. 2013;14:15.","journal-title":"BMC Nephrol"},{"key":"1866_CR14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2215\/CJN.01810407","volume":"3","author":"RM Holden","year":"2008","unstructured":"Holden RM, Harman GJ, Wang M, Holland D, Day AG. Major bleeding in hemodialysis patients. Clin J Am Soc Nephrol. 2008;3:105\u201310.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1866_CR15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.gie.2009.04.014","volume":"71","author":"J Cheung","year":"2010","unstructured":"Cheung J, Yu A, LaBossiere J, Zhu Q, Fedorak RN. Peptic ulcer bleeding outcomes adversely affected by end-stage renal disease. Gastrointest Endosc. 2010;71:44\u20139.","journal-title":"Gastrointest Endosc"},{"key":"1866_CR16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s40620-014-0132-6","volume":"28","author":"H Trivedi","year":"2015","unstructured":"Trivedi H, Yang J, Szabo A. Gastrointestinal bleeding in patients on long-term dialysis. J Nephrol. 2015;28:235\u201343.","journal-title":"J Nephrol"},{"key":"1866_CR17","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.2215\/CJN.02170216","volume":"11","author":"J Ishigami","year":"2016","unstructured":"Ishigami J, Grams ME, Naik RP, Coresh J, Matsushita K. Chronic kidney disease and risk for gastrointestinal bleeding in the community: the Atherosclerosis Risk in Communities (ARIC) study. Clin J Am Soc Nephrol. 2016;11:1735\u201343.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1866_CR18","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3109\/0886022X.2011.560407","volume":"33","author":"CC Liang","year":"2011","unstructured":"Liang CC, Wang IK, Lin HH, Yeh HC, Liu JH, Kuo HL, Hsu WM, Huang CC, Chang CT. Prophylactic use of omeprazole associated with a reduced risk of peptic ulcer disease among maintenance hemodialysis patients. Ren Fail. 2011;33:323\u20138.","journal-title":"Ren Fail"},{"key":"1866_CR19","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1007\/s11606-007-0194-4","volume":"22","author":"CM Bell","year":"2007","unstructured":"Bell CM, Fischer HD, Gill SS, Zagorski B, Sykora K, Wodchis WP, Herrmann N, Bronskill SE, Lee PE, Anderson GM, Rochon PA. Initiation of benzodiazepines in the elderly after hospitalization. J Gener Intern Med. 2007;22:1024\u20139.","journal-title":"J Gener Intern Med"},{"key":"1866_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1177\/1060028014558290","volume":"49","author":"E Reeve","year":"2015","unstructured":"Reeve E, Andrews JM, Wiese MD, Hendrix I, Roberts MS, Shakib S. Feasibility of a patient-centered deprescribing process to reduce inappropriate use of proton pump inhibitors. Ann Pharmacother. 2015;49:29\u201338.","journal-title":"Ann Pharmacother"},{"key":"1866_CR21","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1007\/s10157-019-01772-z","volume":"23","author":"K Niihata","year":"2019","unstructured":"Niihata K, Nishiwaki H, Kurita N, Okada H, Maruyama S, Narita I, Shibagaki Y, Nakaya I. Variations in actual practice patterns and their deviations from the clinical practice guidelines for nephrotic syndrome in Japan: certified nephrologists\u2019 questionnaire survey. Clin Exp Nephrol. 2019;23:1288\u201397.","journal-title":"Clin Exp Nephrol"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-020-01866-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-020-01866-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-020-01866-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T08:57:11Z","timestamp":1617267431000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-020-01866-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,8]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["1866"],"URL":"https:\/\/doi.org\/10.1007\/s10157-020-01866-z","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,8]]},"assertion":[{"value":"29 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have declared that no conflict of interest directly relevant to this article exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The ethics committee of Inagi Municipal Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The research purpose was provided in advance to the survey, and answering the survey would be regarded as informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}